Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No influence of DTNBP1 polymorphisms on the response to aripiprazole.

Neuropsychobiology - 1 Jan 2010

Pae Chi-Un, Chiesa Alberto, Mandelli Laura, Serretti Alessandro

Abstract excerpt

AIMS: The aim of the present study was to investigate possible influences of a panel of markers in the dysbindin gene DTNBP1 (rs3213207, rs1011313, rs2005976, rs760761 and rs2619522) on the clinical outcome and side effects associated to the treatment with aripiprazole in schizophrenic patients....

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Carrier Proteins
Share to Dysbindin
Share to Dystrophin-Associated Proteins
Share to Linkage Disequilibrium
Share to Piperazines
Share to Quinolones
Share to Schizophrenia

Source

Identifiers

PMID: 20829635
DOI: 10.1159/000320863

Genes

DTNBP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20829635-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No influence of DTNBP1 polymorphisms on the response to aripiprazole.PMID 20829635Read ↗

No influence of FAT polymorphisms in response to aripiprazole.Semantic proximity Read ↗

The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.Semantic proximity Read ↗

DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.Semantic proximity Read ↗

Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.Semantic proximity Read ↗

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.Semantic proximity Read ↗

Influence of TAAR6 polymorphisms on response to aripiprazole.Semantic proximity Read ↗

Genomewide association study of movement-related adverse antipsychotic effects.Semantic proximity Read ↗

Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.Semantic proximity Read ↗

HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patientsSemantic proximity Read ↗

Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.Semantic proximity Read ↗

DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia.Semantic proximity Read ↗

Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.